Robin N. Hieber, PharmD, BCPP

Articles by Robin N. Hieber, PharmD, BCPP

Outpatient Adherence to Risperidone Long-Acting Injection Following Discharge From a State Psychiatric Hospital

ByTara L. Purvis, PharmD, BCPP,Leigh Anne Nelson, PharmD, BCPP,Ellie S. R. Elliott, PharmD, BCPP,Robin N. Hieber, PharmD, BCPP,Yifei Liu, BS Pharm, PhD,Richard H. Pham, PharmD,Stuart Munro, MD,an

October 5th 2011

Adherence to risperidone long-acting injection (RLAI) therapy in the outpatient setting was poor. Degree of discharge planning from inpatient hospitalization was not associated with RLAI adherence.

Latest Updated Articles

Outpatient Adherence to Risperidone Long-Acting Injection Following Discharge From a State Psychiatric Hospital
Published: October 5th 2011 | Updated:

Robin N. Hieber, PharmD, BCPP

Articles by Robin N. Hieber, PharmD, BCPP

Outpatient Adherence to Risperidone Long-Acting Injection Following Discharge From a State Psychiatric Hospital

Latest Updated Articles

Trending on Pharmacy Times

A Multifaceted Approach to Navigating Career Transitions in Pharmacy

Earlier Menopause, Reduced Cardiac Function Potentially Linked With Negative Impacts on Brain Health

Menopause Care Varies by Provider, Highlighting Need for Standardized Education